New amidino derivatives and their use as thrombin inhibitors
申请人:AstraZeneca AB
公开号:US20040186090A1
公开(公告)日:2004-09-23
There is provided compounds of formula I
1
wherein R
1
, R
x
, Y, R
y
, n and B have meanings given in the description which are useful as competitive inhibitors of trypsin-like proteases, such as thrombin, and in particular in the treatment of conditions where inhibition of thrombin is required (e.g. thrombosis) or as anticoagulants.
Amidino derivatives and their use as thrombin inhibitors
申请人:AstraZeneca AB
公开号:US07241757B2
公开(公告)日:2007-07-10
There is provided compounds of formula I
wherein R1, Rx, Y, Ry, n and B have meanings given in the description which are useful as competitive inhibitors of trypsin-like proteases, such as thrombin, and in particular in the treatment of conditions where inhibition of thrombin is required (e.g. thrombosis) or as anticoagulants.
[EN] NEW AMIDINO DERIVATIVES AND THEIR USE AS THROMBIN INHIBITORS<br/>[FR] NOUVEAUX DERIVES AMIDINO ET LEUR UTILISATION COMME INHIBITEURS DE LA THROMBINE
申请人:ASTRAZENECA AB
公开号:WO2000035869A1
公开(公告)日:2000-06-22
There is provided compounds of formula (I), wherein R1, Rx, Y, Ry, n and B have meanings given in the description which are useful as competitive inhibitors of trypsin-like proteases, such as thrombin, and in particular in the treatment of conditions where inhibition of thrombin is required (e.g. thrombosis) or as anticoagulants.